Pituitary_adenoma:_correlation_of_half-dose_gadolinium-enhanced_MR_imaging_with_surgical_findings_in_26_patients._Sellar_magnetic_resonance_imaging_studies_obtained_with_half_doses_of_gadopentetate_dimeglumine_(0.05_mmol/kg)_were_prospectively_interpreted_and_retrospectively_rated_in_26_patients_who_subsequently_underwent_transsphenoidal_sellar_surgery_for_suspected_pituitary_adenoma._Studies_included_a_sagittal_scout_view_followed_by_a_non-contrast-material-enhanced,_an_immediate_postcontrast,_and_a_delayed_postcontrast_T1-weighted_image_(obtained_at_1.0_or_1.5_T)._Ten_of_11_confirmed_microadenomas_were_identified_prospectively;_all_were_identifiable_in_retrospect._Macroadenomas_(12_cases)_were_well_demonstrated._The_high_signal_intensity_of_the_posterior_pituitary_and_of_intrasellar_hemorrhage_was_obscured_on_postcontrast_studies._Delayed_images_proved_unnecessary._This_prospective_evaluation_suggests_that_a_half-dose_study_is_comparable_to_retrospective_studies_in_which_full-dose_techniques_were_used_for_detection_of_micro-_and_macroadenomas._Imaging_times_are_reasonably_short,_and_cost_of_contrast_material_is_potentially_reduced._Confirmation_with_larger_studies_is_required,_and_careful_endocrinologic_and_clinical_follow-up_of_nonsurgical_patients_is_necessary.